NMT1 and cancer: In vitro preclinical studies using zelenirstat (previously known as PCLX-001 and DDD86481), a potent small molecule inhibitor of both human NMT proteins, induced dose and time-dependent apoptosis in cancer cells at concentrations lower than those required to kill normal cells.